Skip to content{"success":true,"data":{"id":"twse-mops-1f8g264","title":"公告本公司505(b)(2)新藥BEQIA (TAH3311)美國專利訴訟案","summary":"1.法律事件之當事人: 原告- Bristol Myers Squibb（BMS)and Pfizer Inc.(Pfizer) 被告-泰合生技藥品股份有限公司 2.法律事件之法院名稱或處分機關:United States District Court for DELAWARE 3.法律事件之相關文書案號:1:99-mc-09999 4.事實發生日:115/10/24 5.發生原委(含爭訟標的):美國Bristol Myers Squibb（BMS）藥廠就本公司自主 研發之抗血栓口溶膜新藥BEQIA（TAH3311），於美國提出專利侵權訴訟。本公 司收到訴訟通知之日期為美國時間10月23日。BEQIA為本公司自主研發之口溶 膜新劑型抗血栓藥物。該產品已於2026年6月19日向美國食品藥物管理局（FDA） 重新…","canonicalUrl":"https://mops.twse.com.tw/mops/web/t05st01?TYPEK=all&co_id=6467&encodeURIComponent=1&firstin=1&inpuType=co_id&off=1&step=1&year=115&spoke_date=20261024&spoke_time=110003","sourceName":"TWSE Market Observation Post System","sourceUrl":"https://mops.twse.com.tw/mops/web/t05st01","publishedAt":"2026-10-24T03:00:03.000Z","updatedAt":null,"language":"zh-TW","timeZone":"Asia/Taipei","region":"taiwan","country":"TW","market":"Taiwan","topics":["company-announcement","taiwan"],"relatedAssets":["6467"],"importance":"normal","image":null,"imageRights":null,"contentType":"company-announcement","disclosure":"Official company announcement from 泰合; use the filtered MOPS search page to verify the complete filing.","provenance":{"sourceId":"twse-mops","sourceType":"exchange","official":true,"verification":"PRIMARY_SOURCE_METADATA","fetchedAt":"2026-10-25T02:04:17.179Z","stale":true,"archived":true,"classificationMethod":"RULE_BASED"}},"meta":{"generatedAt":"2026-10-25T02:10:29.853Z","providers":[{"id":"jiguang-news-archive","name":"GOOSUN FINANCE source archive","kind":"news","provider":"goosun_finance","legacy_provider_alias":["jiguang","jiguang_finance"],"status":"degraded","itemCount":1,"cache":"STALE","fetchedAt":"2026-10-25T02:04:17.179Z","sourceUrl":"https://goosun.uk/sources.html","message":"Archived publisher metadata; original publication and fetch times retained. Archive availability is not source freshness."}],"stale":true,"apiVersion":"v2"},"error":null}